Vivek Subbiah, MD
Enriched profileProfessor of Medicine (Oncology) and Professor of Pediatrics (Hematology/Oncology); Jeffrey and Christina Bird Professor; Associate Director for Drug Development and Precision Oncology, Stanford Cancer Institute · Stanford University School of Medicine
Vivek Subbiah is Professor of Medicine (Oncology) and Professor of Pediatrics (Hematology/Oncology); Jeffrey and Christina Bird Professor; Associate Director for Drug Development and Precision Oncology, Stanford Cancer Institute at Stanford University School of Medicine. OpenAlex indexes 1,434 publications with 32,217 citations (h-index 79); ClinicalTrials.gov lists 16 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Vivek Subbiah is Professor of Medicine (Oncology) and Professor of Pediatrics (Hematology/Oncology) at Stanford University School of Medicine / Stanford Cancer Institute (Division of Oncology, Department of Medicine). The public record shows 1,434 publications with 32,217 citations (h-index 79), centered on Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Sarcoma Diagnosis and Treatment. It also documents an investigator role on 12 registered clinical trials.
- Most recent indexed publication: 2026 · Cancer biotherapy & radiopharmaceuticals
- Top research focus: Cancer Genomics and Diagnostics
- 12 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 142 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 405.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L)
Sponsor: National Cancer Institute (NCI)
- TCF-001 TRACK (Target Rare Cancer Knowledge) Study
Sponsor: TargetCancer Foundation
- The Registry of Oncology Outcomes Associated With Testing and Treatment
Sponsor: Taproot Health
Industry payments
43 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202519 payments$20,633openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20256 payments
- AstraZeneca Pharmaceuticals LPProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
100%Corticosteroid100%Dexamethasone sodium phosphate100%Part B, office-administered≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Personalized Radionuclide Therapy via Avidin-Biotin Pretargeting: Biodistribution and Dosimetry of (177)Lu-DOTA-biotin with AvidinOX™ in Solid Tumors.
Cancer biotherapy & radiopharmaceuticals
Article2026 - Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global Implementation.
Journal of clinical oncology
Review2026 - Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.
Journal of clinical oncology
Clinical Trial2026 - Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment.
JCO precision oncology
Review2026
Most-cited works
by citation count (OpenAlex)- 01Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations1,735 citations2015
- 02
- 03
- 04Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers776 citations2020
- 05The next generation of evidence-based medicine530 citations2023
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/vivek-subbiah-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Instagram
instagram.com/viveksubbiahmd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/in/vivek-subbiah-md-bb968633
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
esmo.org/about-esmo/biographies/vivek-subbiah
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗ - Other
onclive.com/authors/vivek-subbiah-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- Combined residency in Internal Medicine and Pediatrics
Case Western Reserve University / MetroHealth, Cleveland, Ohio, completed 2008
2008verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗ - MD
Sri Ramachandra Institute of Higher Education (formerly Sri Ramachandra Medical College and Research Institute), India
2002verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scri.com ↗
Editorial & leadership roles
journal and society appointments- Co-Chair
'Advances in Precision Oncology' Clinical Trials Mini Symposium, AACR Annual Meeting 2026
2026provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗ - Member
ESMO Precision Oncology Working Group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗ - Leadership/committee involvement in ASCO
AACR, and ESMO (tumor-agnostic precision oncology programming)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
- Former: Associate Professor
Department of Investigational Cancer Therapeutics, and Medical Director, Clinical Center for Targeted Therapy, UT MD Anderson Cancer Center
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
Media & interviews
press, podcasts and appearances- Host
JAMA Oncology podcast episode with Dr. Michael Postow (Memorial Sloan Kettering) on immunotherapy for melanoma brain metastases (AMA Ed Hub platform)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗ - Featured video/commentary contributor
OncLive (tissue-agnostic therapies, precision oncology)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Featured interview
AJMC - "AI Should Support Clinicians, Not Replace Them" (Patient-Centered Oncology Care conference)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Heidenreich, MD
Stanford University School of Medicine
Alan Schatzberg, MD
Stanford University School of Medicine
Mark Pegram, MD
Stanford University School of Medicine
Vibeke Strand, MD
Stanford University School of Medicine